Haemonetics (HAE) Cash from Financing Activities (2009 - 2026)

Haemonetics' Cash from Financing Activities history runs 18 years deep, the most recent figure standing at -$101.5 million for Q1 2026.

• In Q1 2026, Cash from Financing Activities rose 32.98% year-over-year to -$101.5 million; the TTM figure through Mar 2026 stood at -$178.5 million (down 264.0% YoY), while the FY2026 annual figure was -$178.5 million, down 264.0% from the prior year.
• Cash from Financing Activities was -$101.5 million for Q1 2026 at Haemonetics, down from $2.0 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $333.7 million in Q2 2024 to a low of -$151.4 million in Q1 2025.
• Historically, Cash from Financing Activities has averaged -$7.9 million across 5 years, with a median of -$8.0 million in 2022.
• Biggest YoY gain for Cash from Financing Activities was 55901.34% in 2024; the steepest drop was 3861.45% in 2024.
• A 5-year view of Cash from Financing Activities shows it stood at -$49.7 million in 2022, then surged by 320.27% to $109.4 million in 2023, then plunged by 98.74% to $1.4 million in 2024, then jumped by 47.32% to $2.0 million in 2025, then tumbled by 5092.57% to -$101.5 million in 2026.
• The last three Cash from Financing Activities figures came in at -$101.5 million (Q1 2026), $2.0 million (Q4 2025), and -$76.6 million (Q3 2025), per Business Quant data.